Sign in
8-K

Current Report

SAB Biotherapeutics, Inc. Filed Acc 0000950170-24-007941

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading sabs-20240126.htm…